|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Property held for lease, net of accumulated depreciation and impairment (Note 3) | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Litigation insurance reimbursement receivable (Note 10) | ||||||||||||||||||||
| Deferred financing costs, net | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Capitalized software and intangible assets, net | ||||||||||||||||||||
| Right-of-use assets, non-current | ||||||||||||||||||||
| Security deposits | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities (Note 4) | ||||||||||||||||||||
| Accrued litigation settlement (Note 10) | ||||||||||||||||||||
| Unearned revenue | ||||||||||||||||||||
| Revolving line of credit, net (Note 5) | ||||||||||||||||||||
| Term loan, net (Note 6) | ||||||||||||||||||||
| Derivative liability (Note 11) | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Revolving line of credit, net (Note 6) | ||||||||||||||||||||
| Term loan, net, non-current (Note 6) | ||||||||||||||||||||
| Lease liabilities, non-current | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Mezzanine equity | ||||||||||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||||||||||
| Series B Convertible Preferred Stock | ||||||||||||||||||||
| Total mezzanine equity | ||||||||||||||||||||
| STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Common stock, $.0001 par value; 250,000,000 shares authorized; 4,792,405 and 4,750,258 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total liabilities, mezzanine equity and stockholders' deficit | ||||||||||||||||||||
Loading...
